Optimizing Glioblastoma Temozolomide Chemotherapy Employing Lentiviral-based Anti-MGMT shRNA Technology-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Optimizing Glioblastoma Temozolomide Chemotherapy Employing Lentiviral-based Anti-MGMT shRNA Technology

Published:2013-03 Issue:3 Volume:21 Page:570-579
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Viel Thomas,Monfared Parisa,Schelhaas Sonja,Fricke Inga B,Kuhlmann Michael T,Fraefel Cornel,Jacobs Andreas H

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference34 articles.

1. The 2007 WHO classification of tumours of the central nervous system;Louis;Acta Neuropathol,2007

2. Central nervous system tumors;Buckner;Mayo Clin Proc,2007

3. Cancer statistics, 2009;Jemal;CA Cancer J Clin,2009

4. Gene therapy for brain cancer: combination therapies provide enhanced efficacy and safety;Candolfi;Curr Gene Ther,2009

5. Analysis of the growth dynamics of angiogenesis-dependent and -independent experimental glioblastomas by multimodal small-animal PET and MRI;Viel;J Nucl Med,2012

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DAXX promotes centromeric stability independently of ATRX by preventing the accumulation of R-loop-induced DNA double-stranded breaks;Nucleic Acids Research;2023-12-01

2. Preclinical Efficacy of LP-184, a Tumor Site Activated Synthetic Lethal Therapeutic, in Glioblastoma;Clinical Cancer Research;2023-07-26

3. A guide through conventional and modern cancer treatment modalities: A specific focus on glioblastoma cancer therapy (Review);Oncology Reports;2022-09-13

4. Research progress of drug resistance mechanisms to temozolomide in glioblastoma;Glioma;2022-07

5. The Phytochemical Potential for Brain Disease Therapy and the Possible Nanodelivery Solutions for Brain Access;Frontiers in Oncology;2022-06-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3